soft-tissue-sarcoma

Documents about soft-tissue-sarcoma

• Retrospective Study of Trabectedin in Soft Tissue Sarcomas#982724ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma#873637ClinicalTrials.gov
• SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma#123451ClinicalTrials.gov
• Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma#890881ClinicalTrials.gov
• Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma#906611ClinicalTrials.gov
• Neoadjuvant Intralesional Injection of Talimogene Laherparepvec#424186ClinicalTrials.gov
• Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma#230418ClinicalTrials.gov
• Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma#870918ClinicalTrials.gov
• Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas#321685ClinicalTrials.gov
• Colorectal Resections in Patients With Retroperitoneal Sarcoma#871245ClinicalTrials.gov
• Stereotactic Radiosurgery for Soft Tissue Sarcoma#871540ClinicalTrials.gov
• Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas#857806ClinicalTrials.gov
• Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients#842318ClinicalTrials.gov
• Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas#855865ClinicalTrials.gov
• Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma#807186ClinicalTrials.gov
• Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)#912611ClinicalTrials.gov
• LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma#222407ClinicalTrials.gov
• Fruquintinib in the Treatment of Soft Tissue Sarcoma#836966ClinicalTrials.gov
• Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas#879615ClinicalTrials.gov
• Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma#967733ClinicalTrials.gov
• Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)#841415ClinicalTrials.gov
• National Swiss Sarcoma Cohort Study#837680ClinicalTrials.gov
• Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)#840907ClinicalTrials.gov
• Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions#853402ClinicalTrials.gov
• TAEST16001 in the Treatment of Soft Tissue Sarcoma#898938ClinicalTrials.gov
• Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma#394748ClinicalTrials.gov
• Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery#121371ClinicalTrials.gov
• S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas#886189ClinicalTrials.gov
• Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery#1009314ClinicalTrials.gov
• GISAR German Interdisciplinary Sarcoma Registry#801358ClinicalTrials.gov
• Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma#873785ClinicalTrials.gov
• High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas#847497ClinicalTrials.gov
• Phase II Study of TAEST16001 in Soft Tissue Sarcoma#858281ClinicalTrials.gov
• Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma#873210ClinicalTrials.gov
• Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma#918253ClinicalTrials.gov
• Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs#981721ClinicalTrials.gov
• Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall#896457ClinicalTrials.gov
• Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma#893554ClinicalTrials.gov
• Actinium Therapy for Late-stage Aggressive Sarcomas#878066ClinicalTrials.gov
• Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma#840974ClinicalTrials.gov
• A Study of IMRT in Primary Bone and Soft Tissue Sarcoma#859953ClinicalTrials.gov
• Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma#849081ClinicalTrials.gov
• Prehabilitation Soft-Tissue Sarcoma of Lower Limb#877278ClinicalTrials.gov
• Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients#883631ClinicalTrials.gov
• Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation#842624ClinicalTrials.gov
• Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma#903468ClinicalTrials.gov
• Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma#888352ClinicalTrials.gov
• Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma#256894ClinicalTrials.gov
• Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention#994608ClinicalTrials.gov
• The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma#238129ClinicalTrials.gov